Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation

Creative Commons License

Türedi S. , Gündüz A. , Menteşe A. , Dasdibi B., Karahan S. C. , Sahin A. , ...More

RESUSCITATION, vol.80, no.9, pp.994-999, 2009 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 80 Issue: 9
  • Publication Date: 2009
  • Doi Number: 10.1016/j.resuscitation.2009.06.007
  • Title of Journal : RESUSCITATION
  • Page Numbers: pp.994-999
  • Keywords: Ischemia-modified albumin, Ischemia, Cardiac arrest, Cardiopulmonary resuscitation, Oxidative stress, NEURON-SPECIFIC ENOLASE, PULMONARY-EMBOLISM, OXIDATIVE STRESS, SERUM, DIAGNOSIS, HYPOTHERMIA, PREDICTION, PROTEIN, S-100, COMA


Background: Early and accurate prediction of survival to hospital discharge following resuscitation after cardiac arrest (CA) is a major challenge. Our aim was to investigate the levels of ischemia-modified albumin (IMA) and malondialdehyde (MDA) in CA patients and whether IMA levels are valuable early marker of post-cardiopulmonary resuscitation prognosis in CA patients.